What does debt issuance cost amortization mean?

Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).

NewAmsterdam Pharma Company NAMS Debt Issuance Cost Amortization

Debt Issuance Cost Amortization at other companies

HES

Hess MidstreamHESM

$3M-38.8%

Warrior Met CoalHCC

$374K-7.7%

Main Street CapitalMAIN

$1.62M+9.8%

NNN REITNNN

$1.75M+19.5%

RepligenRGEN

$4.37M+8.2%

PennyMac Financial Services, Inc.PFSI

$8.65M+22.3%

Other financials

Income statement

See full

Revenue$3.0M+2.1%

Operating income-$58.4M+15.2%

Net income-$48.4M-22.6%

EPS (diluted)-$0.40-17.6%

Balance sheet

See full

Cash & equivalents$457.6M-38.9%

Total debt$23.0K-94.1%

Total equity$665.2M-14.4%

Total assets$732.6M-10.5%

Cash flow

See full

Operating cash flow-$30.6M+16.1%

CapEx$38.0K+138%

Free cash flow-$30.6M+16.0%

Valuation

See full

Market cap$3.67B+63.7%

Profitability

See full

Operating margin-953.6%-3,536pp

Net margin-942.8%-3,477pp

FCF margin-630.1%-6,324pp

Returns & leverage

See full

Return on equity-29.5%-1.8pp

Current ratio9.8×-10.2×

Where this comes from

Reported directly by NewAmsterdam Pharma Company in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfFinancingCostsAndDiscounts.

The official record: NewAmsterdam Pharma Company’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about NewAmsterdam Pharma Company's debt issuance cost amortization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NewAmsterdam Pharma Company's debt issuance cost amortization?: NewAmsterdam Pharma Company (NAMS) reported debt issuance cost amortization of $10K in Q1 2026.
How has NewAmsterdam Pharma Company's debt issuance cost amortization changed year-over-year?: NewAmsterdam Pharma Company's debt issuance cost amortization increased by 101.9% year-over-year, from -$513K to $10K.
What does debt issuance cost amortization mean?: Non-cash amortization of capitalized costs incurred to issue debt (underwriting fees, legal costs, SEC filing fees).